DOI QR코드

DOI QR Code

Association between Polymorphisms in UDP-glucuronosyltransferase 1A6 and 1A7 and Colorectal Cancer Risk

  • Osawa, Kayo (Faculty of Health Sciences, Kobe University Graduate School of Health Sciences) ;
  • Nakarai, Chiaki (Faculty of Health Sciences, Kobe University Graduate School of Health Sciences) ;
  • Akiyama, Minami (Faculty of Health Sciences, Kobe University Graduate School of Health Sciences) ;
  • Hashimoto, Ryuta (Faculty of Health Sciences, Kobe University Graduate School of Health Sciences) ;
  • Tsutou, Akimitsu (Faculty of Health Sciences, Kobe University Graduate School of Health Sciences) ;
  • Takahashi, Juro (Faculty of Health Sciences, Kobe University Graduate School of Health Sciences) ;
  • Takaoka, Yuko (Clinical Laboratory, Otemae Hospital) ;
  • Kawamura, Shiro (Department of Surgery, National Hospital Organization Kobe Medical Center) ;
  • Shimada, Etsuji (Department of Surgery, National Hospital Organization Kobe Medical Center) ;
  • Tanaka, Kenichi (Department of Surgery, Hyogo Cancer Center) ;
  • Kozuka, Masaya (Department of Surgery, Kobe Rosai Hospital) ;
  • Yamamoto, Masahiro (Department of Surgery, Kobe Rosai Hospital) ;
  • Kido, Yoshiaki (Faculty of Health Sciences, Kobe University Graduate School of Health Sciences)
  • Published : 2012.05.30

Abstract

Genetic polymorphisms of uridine diphosphate-glucuronosyltransferases 1A6 (UGT1A6) and 1A7 (UGT1A7) may lead to genetic instability and colorectal cancer carcinogenesis. Our objective was to measure the interaction between polymorphisms of these repair genes and tobacco smoking in colorectal cancer (CRC). A total of 68 individuals with CRC and 112 non-cancer controls were divided into non-smoker and smoker groups according to pack-years of smoking. Genetic polymorphisms of UGT1A6 and UGT1A7 were examined using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). We found a weak association of UGT1A6 polymorphisms with CRC risk (crude odds ratio [OR], 1.65;95% confidence interval [95% CI], 0.9-3.1, P=0.107; adjusted OR 1.95%, 95% CI 1.0-3.8, P=0.051). The ORs for the UGT1A7 polymorphisms were statistically significant (crude OR: 26.40, 95% CI: 3.5-198.4, P=0.001; adjusted OR: 21.52, 95% CI: 2.8-164.1, P=0.003). The joint effect of tobacco exposure and UGTIA6 polymorphisms was significantly associated with colorectal cancer risk in non-smokers (crude OR, 2.11; 95% CI, 0.9-5.0, P=0.092; adjusted OR 2.63, 95% CI, 1.0-6.7, P=0.042). In conclusion, our findings suggest that UGT1A6 and UGT1A7 gene polymorphisms are associated with CRC risk in the Japanese population. In particualr, UGT1A6 polymorphisms may strongly increase CRC risk through the formation of carcinogens not associated with smoking.

Keywords

References

  1. Araki J, Kobayashi Y, Iwasa M, et al (2005). Polymorphism of UDP-glucuronosyltransferase 1A7 gene: a possible new risk factor for lung cancer. Eur J Cancer, 41, 2360-5. https://doi.org/10.1016/j.ejca.2005.04.043
  2. Chan AT, Tranah GJ, Giovannucci EL, et al (2005). Genetic variants in the UGT1A6 enzyme, aspirin use, and the risk of colorectal adenoma. J Natl Cancer Inst, 97, 457-60. https://doi.org/10.1093/jnci/dji066
  3. Chen K, Jin M, Zhu Y, et al (2006). Genetic polymorphisms of the uridine diphosphate glucuronosyltransferase 1A7 and colorectal cancer risk in relation to cigarette smoking and alcohol drinking in a Chinese population. J Gastroenterol Hepatol, 21, 1036-41. https://doi.org/10.1111/j.1440-1746.2005.04032.x
  4. Ciotti M, Marrone A, Potter C, et al (1997). Genetic polymorphism in the human UGT1A6 (planar phenol) UDPglucuronosyltransferase: pharmacological implications. Pharmcogenetics, 7, 485-95. https://doi.org/10.1097/00008571-199712000-00007
  5. Fang JL, Lazarus P (2004). Correlation between the UDP-glucuronosyltransferase (UGT1A1) TATAA box polymorphism and carcinogen detoxification phenotype: significantly decreased glucuronidating activity against benzo(a)pyrene-7,8-dihydrodiol(-) in liver microsomes from subjects with the UGT1A1*28 variant. Cancer Epidemiol Bioarkers Prev, 13, 102-9. https://doi.org/10.1158/1055-9965.EPI-03-0070
  6. Guillemette C, Ritter JK, Auyeung DJ, et al (2000). Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene. Pharmacogenetics, 10, 629-44. https://doi.org/10.1097/00008571-200010000-00006
  7. Hubner RA, Muir KR, Liu JF, et al (2006). United Kingdom Colorectal Adenoma Prevention Consortium. Genetic variants of UGT1A6 influence risk of colorectal adenoma recurrence. Clin Cancer Res, 12, 6585-9. https://doi.org/10.1158/1078-0432.CCR-06-0903
  8. Jin CJ, Miners JO, Burchell B, et al (1993). The glucuronidation of hydroxylated metabolites of benzo[a]pyrene and 2-acetylaminofluorene by cDNA-expressed human UDP-glucuronosyltransferases. Carcinogenesis, 14, 2637-9. https://doi.org/10.1093/carcin/14.12.2637
  9. Joshi AD, Corral R, Siegmund KD, et al (2009). Red meat and poultry intake, polymorphisms in the nucleotide excision repair and mismatch repair pathways and colorectal cancer risk. Carcinogenesis, 30, 472-9. https://doi.org/10.1093/carcin/bgn260
  10. Kasahara M, Osawa K, Yoshida K, et al (2008). Association of MUTYH Gln324His and APEX1 Asp148Glu with colorectal cancer and smoking in a Japanese population. J Exp Clin Cancer Res, 27, 49. https://doi.org/10.1186/1756-9966-27-49
  11. Nagar S, Remmel RP (2006). Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer. Oncogene, 25, 1659-72. https://doi.org/10.1038/sj.onc.1209375
  12. Orzechowski A, Schrenk D, Bock-Hennig BS, et al (1994). Glucuronidation of carcinogenic arylamines and their N-hydroxy derivatives by rat and human phenol UDPglucuronosyltransferase of the UGT1 gene complex. Carcinogenesis, 15, 1549-53. https://doi.org/10.1093/carcin/15.8.1549
  13. Paz-Elizur T, Sevilya Z, Leitner-Dagan Y, et al (2008). DNA repair of oxidative DNA damage in human carcinogenesis: potential application for cancer risk assessment and prevention. Cancer Lett, 266, 60-72. https://doi.org/10.1016/j.canlet.2008.02.032
  14. Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29. https://doi.org/10.3322/caac.20138
  15. Strassburg CP, Vogel A, Kneip S, et al (2002). Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer. Gut, 50, 851-6. https://doi.org/10.1136/gut.50.6.851
  16. Tang KS, Chiu HF, Chen HH, et al (2005). Link between colorectal cancer and polymorphisms in the uridinediphosphoglucuronosyltransferase 1A7 and 1A1 genes. World J Gastroenterol, 11, 3250-4. https://doi.org/10.3748/wjg.v11.i21.3250
  17. Van der Logt EM, Bergevoet SM, Roelofs HM, et al (2004). Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk. Carcinogenesis, 25, 2407-15. https://doi.org/10.1093/carcin/bgh251
  18. Yoshida K, Osawa K, Kasahara M, et al (2007). Association of CYP1A1, CYP1A2, GSTM1 and NAT2 gene polymorphisms with colorectal cancer and smoking. Asian Pac J Cancer Prev, 8, 438-44.
  19. Zhao Y, Deng X, Wang Z, et al (2012). Genetic polymorphisms of DNA repair genes XRCC1 and XRCC3 and risk of colorectal cancer in Chinese population. Asian Pac J Cancer Prev, 13, 665-9. https://doi.org/10.7314/APJCP.2012.13.2.665
  20. Zheng Z, Park JY, Guillemette C, et al (2001). Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk. J Natl Cancer Inst, 93, 1411-8. https://doi.org/10.1093/jnci/93.18.1411

Cited by

  1. Polymorphic Expression of UDP-Glucuronosyltransferase UGTlA Gene in Human Colorectal Cancer vol.8, pp.2, 2013, https://doi.org/10.1371/journal.pone.0057045
  2. Tissue-specific patterns of gene expression in the epithelium and stroma of normal colon in healthy individuals in an aspirin intervention trial vol.16, pp.1, 2015, https://doi.org/10.1186/s12881-015-0161-6
  3. Differential expression of the UGT1A family of genes in stomach cancer tissues vol.36, pp.8, 2015, https://doi.org/10.1007/s13277-015-3253-1